Patritumab (Anti-ERBB3 / HER3), 1mg*5

Patritumab (Anti-ERBB3 / HER3), 1mg*5

Anti-EphA2 (MEDI-547), 1mg

Anti-EphA2 (MEDI-547), 1mg

Patritumab (Anti-ERBB3 / HER3), 1mg*25

19.336,31 RON
SKU
SKM_A2506_1mg*25

Patritumab (Anti-ERBB3 / HER3) is a neutralizing monoclonal antibody targeting ERBB3. Patritumab shows a synergy with Cetuximab (HY-P9905), potently inhibits the phosphorylation of EGFR, HER2, HER3, ERK, and AKT. Patritumab also induces cell apoptosis and suppresses the growth of pancreatic, non-small cell lung cancer, and colorectal cancer xenograft tumors. MW: 145.5 KD.

Mai multe informatii
Price 16.249,00 RON (preturile sunt fara TVA)
Description

Patritumab (Anti-ERBB3 / HER3) is a neutralizing monoclonal antibody targeting ERBB3. Patritumab shows a synergy with Cetuximab (HY-P9905), potently inhibits the phosphorylation of EGFR, HER2, HER3, ERK, and AKT. Patritumab also induces cell apoptosis and suppresses the growth of pancreatic, non-small cell lung cancer, and colorectal cancer xenograft tumors. MW: 145.5 KD.